-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

401.P1.27 401. Blood Transfusion: Poster I

Symposia: Blood Transfusion Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Alexander Roeth, MD1, Sigbjørn Berentsen2*, Wilma Barcellini, MD3*, Shirley D'Sa4*, Bernd Jilma5, Marc Michel, MD6*, Ilene C. Weitz7*, Masaki Yamaguchi8*, Jun-ichi Nishimura9, Josephine M.I. Vos10*, Joan Cid11*, Michael Storek12*, Nancy Wong12*, Ronnie Yoo13*, Jennifer Wang12*, Deepthi Vagge14*, Marek Wardecki15*, Frank Shafer16*, Michelle Lee, MD17* and Catherine M. Broome, MD18

1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany
2Department of Research and Innovation, Haugesund Hospital, Haugesund, NOR
3Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
4UCLH Centre for Waldenström’s Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom
5Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
6Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France
7Keck School of Medicine of USC, Los Angeles, CA
8Ishikawa Prefectural Central Hospital, Kanazawa, Japan
9Osaka University Graduate School of Medicine, Suita, Japan
10Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
11Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, ICMHO, IDIBAPS, Hospital Clínic, Barcelona, Spain
12Sanofi, Cambridge
13Sanofi, Boston, MA
14IQVIA, Bangalore, India
15Sanofi, Warsaw, MA, Poland
16Sanofi, Bridgewater
17Global Project Head, Rare Disease and Rare Blood Disorders Development, Sanofi, Bridgewater, MA
18Division of Hematology, MedStar Georgetown University Hospital, Washington, DC

Huiying Zhi, PhD1, Guoping Fu, PhD2*, Renren Wen, PhD2, Demin Wang, PhD2, Peter J. Newman, PhD3 and Debra K. Newman, PhD2

1Blood Center of Wisconsin, Milwaukee, WI
2Blood Research Institute, Versiti, Milwaukee, WI
3BLOOD CENTER OF WISCONSIN, Milwaukee, WI

Shangari Vijenthira1, Samia Saeed2*, Liying Zhang, PhD3*, Reda Siddiqui4*, Sophia Massin2*, Chantal Armali3*, Amie Kron, MSc, BSc5*, Omar Hajjaj3*, Iran Rashedi, MD PhD3*, Harley Meirovich3*, Farzana Tasmin, MPH, MBBS, MT2*, Widad Abdulwabab3*, Lisa Manswell6*, Cesario Ilagan7*, Jacob Pendergrast, MD, FRCPC8,9, Lani Lieberman, MD10,11*, Donald R. R. Branch, PhD9,12, Aditi Khandelwal, MD13, Nadine Shehata, MD, FRCPC, MSc14,15, Katerina Pavenski, MD, FRCPC9,16, Yulia Lin, MD, FRCPC17, Jeannie L Callum, MD9,18 and Christine M. Cserti-Gazdewich, BSc, MD, FRCPC2,9

1Laboratory Medicine Program, University Health Network, Kingston, ON, Canada
2Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
3Sunnybrook Health Sciences Centre, Toronto, ON, Canada
4Laboratory Medicine Program, University Health Network, Toronto, Canada
5Sunnybrook Health Sciences Centre, Toronto, ON, CAN
6St. Michael's Hospital, Toronto, ON, Canada
7Mount Sinai Hospital, Toronto, ON, Canada
8Laboratory Medicine Program, Toronto General Hospital, Toronto, ON, Canada
9Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
10Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Canada
11Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON, Canada
12Centre for Innovation, Canadian Blood Services, Toronto, ON, CAN
13Canadian Blood Services, Toronto, ON, Canada
14Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
15Mount Sinai Hospital, Toronto, ON, CAN
16St. Michael’s Hospital, Toronto, ON, Canada
17Sunnybrook Health Sciences Centre, Toronto, Canada
18Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada

Yanhui Wei1*, Tianyi Xia2*, Jiale Ma1,3*, Xiaohui Gao1,4* and Zheng Ge, MD, PhD1

1Department of Hematology, Zhongda Hospital, School of Medicine, Institute of Hematology, Southeast University, Nanjing, China
2Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China
3Department of Hematology,Xuzhou Central Hospital, Xuzhou, China
4Department of Hematology, Affiliated Hospital of Yangzhou University, Yangzhou, China

Haisle Moon1,2*, Peter Rahfeld, PhD3*, Iren Constantinescu2*, Matthew Drayton4*, Dana V. Devine, PhD5,6, Stephen G Withers, PhD7,8* and Jayachandran N Kizhakkedathu, PhD9,10,11*

1Pathology and Laboratory Medicine, University of British Columbia, Vacnovuer, BC, Canada
2Centre for Blood Research, Vancovuer, BC, Canada
3Chemistry, University of British Columbia, Vancovuer, BC, Canada
4Centre for Blood Research, Vancouver, BC, Canada
5Canadian Blood Services, Vancouver, BC, Canada
6Canadian Blood Services UBC Centre for Blood Research, Vancouver, BC, Canada
7Chemistry, University of British Columbia, Vacnovuer, BC, Canada
8Biochemistry and Molecular Biology, University of British Columbia, Vancovuer, BC, Canada
9Pathology and Laboratory Medicine, University of British Columbia, Vancovuer, BC, Canada
10Centre for blood research, University of British Columbia, Vancouver, BC, Canada
11Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada

Vinay K. Giri, MD1*, Muharrem Yunce, MD2*, Srikanth Muppidi, MD3*, Kavitha J. Ramchandran, MD4*, Tamiko R. Katsumoto, MD5* and Beth A Martin-Kool, MD6

1Department of Medicine, Stanford University School of Medicine, Stanford, CA
2Department of Pathology, Division of Transfusion Medicine, Stanford University School of Medicine, Stanford, CA
3Department of Neurology and Neurosciences, Stanford University School of Medicine, Stanford, CA
4Department of Medicine, Division of Medical Oncology, Stanford University School of Medicine, Stanford, CA
5Department of Medicine, Division of Rheumatology, Stanford University School of Medicine, Stanford, CA
6Department of Medicine, Division of Hematology, Stanford, Stanford, CA

Simone E. Dekker, MD, PhD1, Jacqueline Chang, MD1*, Carley Little, MD1*, Rafael Ornelas, MD2*, Janice Jou, MD, MHS2*, Trisha E. Wong, MD, MS3, Martin Schreiber, MD4* and Joseph J Shatzel, MD5

1Department of Medicine, Oregon Health & Science University, Portland, OR
2Division of Gastroenterology and Hepatology, Department of Medicine, Oregon Health & Science University, Portland, OR
3Division of Hematology and Oncology, Department of Pediatrics, Oregon Health & Science University, Portland, OR
4Department of Surgery, Oregon Health & Science University, Portland, OR
5Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR

Bruno Fattizzo, MD1*, Alexander Roeth, MD2, Catherine M. Broome, MD3, Umer Khan, MS4*, Frank Shafer5*, Matias Cordoba, MD6* and Wilma Barcellini, MD7*

1Universita Degli Studi di Milano, Milano, Milano, Italy
2University Hospital Essen, Essen, Germany
3Medstar Georgetown University Hospital, Washington, DC
4Biostatistics, Sanofi US Services Inc., Bridgewater, NJ
5Sanofi, Bridgewater
6Sanofi Genzyme, Cambridge
7Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

*signifies non-member of ASH